Abstracts of the 1st Immunotherapy of Cancer Conference (ITOC1)

S2. Therapeutic strategies based on overcoming immune resistance mechanisms within the melanoma tumour microenvironment

T Gajewski

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I1

Published on: 12 March 2014

S5. Proffered paper: Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703: clinical and immunological predictive pretreatment factors of activity in the IMPACT trial

H Schmoll, BW Wittig, DA Arnold, JRK Riera-Knorrenschild, DN Nietsche, HK Kroening, FM Mayer, JA Andel, RZ Ziebermayr and WS Scheithauer

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I2

Published on: 12 March 2014

S6. Proffered paper: Anti-tumour immunomodulatory activity of heat shock protein Hsp70 in therapy of malignant brain tumours: preclinical and clinical data

M Shevtsov, A Kim, W Khachatryan, A Pozdnyakov, I Romanova, I Guzhova and B Margulis

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I3

Published on: 12 March 2014

S7. KEYNOTE LECTURE: Immunobiological properties of the human cancer stem cells

C Maccalli, EZ Elisabetta Zambon, FC Filippo Capocefalo and GP Giorgio Parmiani

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I4

Published on: 12 March 2014

S9. Proffered paper: Identification of novel immune checkpoints as targets for cancer immunotherapy

G Cojocaru, G Rotman, O Levy, A Toporik, L Dassa, I Vaknin, S Sameah-Greenwald, I Barbiro, E Neria and Z Levine

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I5

Published on: 12 March 2014

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4

P Sharma

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I6

Published on: 12 March 2014

S38. Many reasons for combining immunotherapy with chemotherapy to enhance anti tumour response

A Dalgleish, D Fowler, A Gravett, R Allen and W Liu

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I7

Published on: 12 March 2014

S41. Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer

C Klein

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I8

Published on: 12 March 2014

S43. Dendritic cell vaccination combined with CTLA4 blockade

K Thielemans and B Neyns

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I9

Published on: 12 March 2014

S47. Tumour infiltrating lymphocytes - a predictive marker?

J Galon

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I10

Published on: 12 March 2014

S48. Biomarker development for ipilimumab and prostate GVAX treatment

T de Gruijl, S Santegoets, A Stam, S Lougheed, K Jooss, N Sacks, T Harding, K Hege, W Gerritsen and A van den Eertwegh

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I11

Published on: 12 March 2014

S50. Proffered paper: Complex tumour microenvironment screening platform captures biological responses of cancer therapeutics

H Layman, J Melrose, W Tang, N Brown, D Nguyen, A Melton, M Polokoff, E Berg and A O'Mahony

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I12

Published on: 12 March 2014

S75. KEYNOTE LECTURE: Basic concept for the understanding of cancer mediated immune rejection

F Marincola and E Wang

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I13

Published on: 12 March 2014

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes

I Svane, R Andersen and M Donia

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I14

Published on: 12 March 2014

S77. Proffered paper: In vitro induced response patterns of antileukemic T-cells – characterization by combination of functional assays, spectratyping and next generation sequencing

S Reuther, P Krell, FR Schuster, C Grabrucker, A Liepert, T Kroell, HJ Kolb, A Borkhardt, R Buhmann and H Schmetzer

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I15

Published on: 12 March 2014

S78. Proffered paper: High-affinity CD20-specific TCRs suitable for adoptive immunotherapy can be readily isolated from the allo-repertoire using reverse immunology

L Jahn, P Hombrink, C Hassan, MGD Kester, MP Schoonakker, JHF Falkenburg, P van Veelen and MHM Heemskerk

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I16

Published on: 12 March 2014

S79. CAR strategies in solid tumours

C Rossig

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I17

Published on: 12 March 2014

S80. Prolongation of T cell response by OX40 co-signalling CARS

H Abken

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I18

Published on: 12 March 2014

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy

S Grassmann, P Peters, Y Zeng, J Schmollinger, S Endres and S Kobold

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I19

Published on: 12 March 2014

S82. Proffered paper: In-vivo testing of PSMA-targeted T-cell immunotherapy for prostate cancer

Z Liu, SB Papa, J Morris and J Maher

Journal for ImmunoTherapy of Cancer 2014 2(Suppl 2):I20

Published on: 12 March 2014